Latest FDA Special Protocol Assessment Stories
ROCKVILLE, Md., Nov. 17, 2014 /PRNewswire/ -- TissueGene, Inc., a clinical stage biopharmaceutical company, has received recommendations from the U.S.
WALTHAM, Mass., Feb.
Marketing Approval Triggers Milestone Payment to Keryx NEW YORK, Jan. 17, 2014 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc.
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.